Stockscreener 앱 받기
3.77
0.27%
0.01
전일 마감가:
$3.76
열려 있는:
$3.74
하루 거래량:
21,889
Relative Volume:
0.11
시가총액:
$20.38M
수익:
$15.00M
순이익/손실:
$2.71M
주가수익비율:
2.9627
EPS:
1.2725
순현금흐름:
$-2.89M
1주 성능:
+0.27%
1개월 성능:
-3.08%
6개월 성능:
-18.75%
1년 성능:
-68.37%
1일 변동 폭
$3.73
$3.78
1주일 범위
$3.71
$3.84
52주 변동 폭
$3.19
$21.40
Neuphoria Therapeutics Inc Stock (NEUP) Company Profile
명칭
Neuphoria Therapeutics Inc
전화
781-439-5551
주소
100 SUMMIT DR, BURLINGTON
Compare NEUP vs VRTX, REGN, ARGX, MRNA, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NEUP
Neuphoria Therapeutics Inc
|
3.77 | 21.35M | 15.00M | 2.71M | -2.89M | 1.2725 |
VRTX
Vertex Pharmaceuticals Inc
|
546.12 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
827.72 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,033.15 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.55 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.02 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Neuphoria Therapeutics Inc Stock (NEUP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-09-28 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2023-09-28 | 재확인 | Maxim Group | Buy |
| 2022-01-10 | 개시 | Berenberg | Buy |
| 2022-01-10 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-01-10 | 개시 | Evercore ISI | Outperform |
| 2022-01-10 | 개시 | H.C. Wainwright | Buy |
모두보기
Neuphoria Therapeutics Inc 주식(NEUP)의 최신 뉴스
ACTU Stock Price and Chart — NASDAQ:ACTU - TradingView
Neuphoria Therapeutics Inc (NEUP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
NEUP Q2 2026 Earnings: Narrower-Than-Expected Loss Delivers 90.9% EPS SurpriseGeographic Revenue Trends - Vinanet
Neuphoria Therapeutics (NEUP) Pulls Back to $3.82 as Traders Eye Key Support ZoneVanna Flow - dars.gov.et
Neuphoria Therapeutics (NEUP) Pulls Back 1.27% to $3.9, Holds Above Key SupportKeltner Channel - dars.gov.et
Are CBZ, SAFT, NEUP, TCBK Obtaining Fair Deals for their Shareholders? - tradingview.com
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
CNSY Stock Price and Chart — NASDAQ:CNSY - TradingView
Neuphoria Therapeutics (NEUP) Slips to $3.88 as Bulls Defend Key SupportSector ETF Flow - dars.gov.et
NEUP Q2 2026 Earnings: Narrower-Than-Expected Loss Signals Lean Cost ManagementEarnings Decline Risk - dars.gov.et
NEUP Q2 2026 Earnings: Narrower-than-Expected Loss Delivers 90.9% EPS Surprise Amid Stock PullbackEarnings Weakness Phase - Vinanet
Scancell merges with Nasdaq shell Neuphoria to fund USD 89m Phase III melanoma trial - allsci.com
Neuphoria Therapeutics (NEUP) Holds Near $3.93 as Biotech Stock Tests Key Technical LevelsStock Analysis - vinanet.vn
Neuphoria Therapeutics (NEUP) Gains 3.55% as Stock Tests Key Resistance Near $4.14Chandelier Stop - dars.gov.et
Advising Nasdaq-listed Neuphoria Therapeutics Inc. On Its USD250M Merger With AIM-listed Scancell Holdings - Mondaq
Neuphoria Therapeutics Inc. (NEUP) Q2 2026 Earnings: Loss Narrows Sharply, Exceeding ExpectationsEPS Growth Report - dars.gov.et
Advising Nasdaq-listed Neuphoria Therapeutics Inc. on its USD250M merger with AIM-listed Scancell Holdings - Winston Taylor
Halper Sadeh LLC is Investigating Whether SAFT, NEUP, NRIM are Obtaining Fair Deals for their Shareholders - GlobeNewswire
Neuphoria Therapeutics Inc (NEUP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Neuphoria Therapeutics Inc (NASDAQ: NEUP) Share Price, NEUP Stock News, NEUP Share Price & Updates - Kalkine
NEUP|Neuphoria Therapeutics Inc|Price:3.970|Chg%:+0.330 - TradingKey
Neuphoria Therapeutics Inc (NEUP) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Neuphoria Therapeutics Inc (NEUP) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Neuphoria Therapeutics Inc (NEUP) Income Statement - tradingkey.com
Neuphoria Therapeutics (NEUP) Drops 7%: Key Levels in Focus After Sharp DeclineFibonacci Time Zone - po-news-eg.net
Neuphoria Therapeutics Inc. Revenue Breakdown – NASDAQ:NEUP - TradingView
NEUP|Neuphoria Therapeutics Inc|Price:3.810|Chg%:+0.170 - TradingKey
Neuphoria Therapeutics Inc (NEUP) Cash Flow - TradingKey
Neuphoria Therapeutics Market Sentiment - Benzinga España
NEUP Stock Alert: Halper Sadeh LLC is Investigating Whether Neuphoria Therapeutics Inc. is Obtaining a Fair Price for its Shareholders - Business Wire
Monteverde & Associates investigates Neuphoria Therapeutics merger fairness for shareholders. - Pluang
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Neuphoria Therapeutics, Inc. (NASDAQ: NEUP) - PR Newswire
Neuphoria Therapeutics (NEUP) Proxy filing Summary - Quartr
Neuphoria Therapeutics to Merge with Scancell Holdings - TipRanks
Neuphoria Therapeutics (Nasdaq: NEUP) to be acquired by Scancell - Stock Titan
Neuphoria Therapeutics to Merge With Scancell; Holders to Receive ADSs Plus CVRs - TradingView
Scancell and Neuphoria agree all-share merger supported by up to US$89 million financing - Yahoo Finance UK
NEUPHORIA THERAPEUTICSSCANCELL EXPECTS TO SECURE UP TO $89 MLN IN FINANCING - Moomoo
Neuphoria Therapeutics Agrees to All-Share Takeover by Scancell - Moomoo
Scancell Holdings plc agreed to acquire Neuphoria Therapeutics Inc. for $34.7 million. - marketscreener.com
Scancell, Neuphoria Therapeutics Agree All-share Merger - Moomoo
Scancell merges with Neuphoria after Merck axes trial; AstraZeneca breast cancer drug approved in EU - Endpoints News
Scancell agrees to buy Neuphoria, combined firm set to list on Nasdaq - marketscreener.com
Scancell And Neuphoria Therapeutics Announce Merger Agreement - TradingView
Scancell and Neuphoria Therapeutics Announce Merger Agreement and Financing - The Manila Times
Scancell And Neuphoria Therapeutics Announce Merger Agreement And Financing - TradingView
Scancell to join Nasdaq through Neuphoria merger and $89 million funding package - Proactive financial news
Scancell Holdings Secures £9 Million via UK Share Placing Ahead of Nasdaq Merger with Neuphoria Therapeutics - Kalkine Media
MRK, NEUP stocks drop as Merck scraps another Alzheimer’s drug trial under Neuphoria partnership - MSN
Price to book forward of Neuphoria Therapeutics Inc. – NASDAQ:NEUP - TradingView
Enterprise value to revenue forward of Neuphoria Therapeutics Inc. – NASDAQ:NEUP - TradingView
Neuphoria Therapeutics Inc (NEUP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.86%
0.31%
자본화:
|
볼륨(24시간):